Journal: Frontiers in Pharmacology
Article Title: Hydroalcoholic extract of Buxus sempervirens shows antiproliferative effect on melanoma, colorectal carcinoma and prostate cancer cells by affecting the autophagic flow
doi: 10.3389/fphar.2023.1073338
Figure Lengend Snippet: Effect of treatment for 24–48–72 h with Buxus sempervirens hydroalcoholic extract (BSHE) on cell proliferation and viability as determined by the trypan blue exclusion test (A) and the MTS assay (B) . HS27: normal human dermal fibroblasts; HCT116: human colorectal carcinoma cells; BMel: human melanoma cells; PC3: human prostate cancer cells. Graphs on the left columns of both panels show the effect of various BSHE concentrations ( x -axis, logarithmic values) on normalized growth rate inhibition (GR, see Materials and Methods) as reported on y -axis. Graphs on the right columns of both panels show the effect of various BSHE concentrations ( x -axis, logarithmic values) on relative cell viability ( y -axis), i.e., number of viable cells (or net A490 nm using MTS assay) under BSHE treatment versus BSHE-untreated controls. BSHE concentrations were 3.9, 7.8, 15.6, 31.2, 62.5, 125, 250, and 500 μg/mL. Means ± S.D. were reported (n = 3 for the trypan blue exclusion test, n = 4 for the MTS assay). Graphs were obtained from the online tool GR calculator ( www.grcalculator.org ; see Materials and Methods).
Article Snippet: The Hs27 normal human dermal fibroblast cell line (ATCC 1634-CRL), the HCT116 human colorectal carcinoma cell line (ATCC CCL-247) and the PC3 human prostate cancer cell line (ATCC 11435-CRL) were purchased by American Type Culture Collection (Manassas, Va), while the BMel human melanoma cell line was a gift from Prof. P.G.Natali (“Regina Elena” Institute for Cancer Research, Rome, Italy).
Techniques: MTS Assay, Inhibition